Our markets
With the overall aim of increasing patient engagement to life-changing treatment and medication, our focus is on long-term conditions, cancer, and rare diseases.
Our mission is to give patients control of their health through knowledge, choice, convenience and connection
Intelligent Insights
Our Intelligent Insights are enabling healthcare professionals, pharmaceutical companies and biotechs to improve patient health outcomes.
Long-term conditions
As a leading life sciences business, we help those with long-term conditions get the best from their medicines.
Cancer treatments
Delivering a range of treatments, we are the UK’s leading provider of cancer in-home care.
Rare diseases & orphan drugs
We’re a global network dedicated to getting rare and orphan medicines to hard-to-reach patients worldwide.
Delivering vital medicines
Cancer care at home
Increasing global access
Powered by insight
Stay up to date with the news, find out more about our latest developments and learn from experts across Sciensus.
Case Studies
Supporting the NHS’s service recovery through the Sciensus virtual ward
The COVID-19 pandemic placed well-documented strain on the NHS’s capacity to deliver planned services, such as surgery. As a result,…
News
Promising breakthrough for patients with rare form of cancer
A recent breakthrough in the treatment of malignant pleural mesothelioma (MPM) , published in JAMA oncology, may be a pivotal…
News
Sciensus continues to extend the full range of its services across Europe
Sciensus, a life sciences business, specialising in patient access, engagement and insight solutions has announced that it is extending the…